Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > " Missing 18 Pending patients data"

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Feb 13, 2023 12:27pm

164 Views

Post# 35283237

RE:RE:" Missing 18 Pending patients data"

I'm not going to say anyone's view is wright or wrong. I like the analysis here being done. To me, what is important now is each time we get new data. The late data % numbers, that are quite large % CR seem to shift from right to left, displacing the worser % numbers that were there in the previous period.

As long as we continue to see that we will have Decent CR % numbers when it is time for TLT to apply for AA. Probably in the 40 + % CR/PRs.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario